BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33465778
Number of visits today
87
Number of downloads
16647294
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Davies SC, Hussein IM, Nguyen TM, Parker CE, Khanna R, Jairath V. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;1:CD012381. [PMID: 31984480 DOI: 10.1002/14651858.CD012381.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mateen B, Patel M, Akobeng A, Gordon M, Hayee B. Systematic review: The effectiveness of 6-thioguanine nucleotide-based dose optimisation of thiopurines in the treatment of inflammatory bowel disease. Wellcome Open Res 2023;8:60. [DOI: 10.12688/wellcomeopenres.18846.1] [Reference Citation Analysis]
2 Lu Y, Cao C, Pan X, Liu Y, Cui D. Structure design mechanisms and inflammatory disease applications of nanozymes. Nanoscale 2022;15:14-40. [PMID: 36472125 DOI: 10.1039/d2nr05276h] [Reference Citation Analysis]
3 Yamamoto-Furusho JK, Parra-Holguín NN. Emerging therapeutic options in inflammatory bowel disease. World J Gastroenterol 2021; 27(48): 8242-8261 [DOI: 10.3748/wjg.v27.i48.8242] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Mateen BA, Patel M, Akobeng AK, Gordon M, Hayee B. 6-thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews 2021;2022. [DOI: 10.1002/14651858.cd014795] [Reference Citation Analysis]
5 Kumar N, Kuang L, Villa R, Kumar P, Mishra J. Mucosal Epithelial Jak Kinases in Health and Diseases. Mediators Inflamm 2021;2021:6618924. [PMID: 33814980 DOI: 10.1155/2021/6618924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Gurusamy K. How does tofacitinib compare with placebo for maintaining remission in people with ulcerative colitis? Cochrane Clinical Answers 2020. [DOI: 10.1002/cca.2986] [Reference Citation Analysis]
7 Davies SC, Hussein IM, Nguyen TM, Parker CE, Khanna R, Jairath V. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2020;1:CD012381. [PMID: 31984480 DOI: 10.1002/14651858.CD012381.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345